Today, the CEO & President of Bruker Corp, Frank Laukien, exercised options of Bruker Corp (NASDAQ: BRKR) for $1.37M.
Following Frank Laukien’s last BRKR Buy transaction on August 10, 2017, the stock climbed by 4.7%.
See today’s analyst top recommended stocks >>
Based on Bruker Corp’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $432 million and quarterly net profit of $27 million. In comparison, last year the company earned revenue of $385 million and had a net profit of $21.6 million. BRKR’s market cap is $4.96B and the company has a P/E ratio of 59.96. Currently, Bruker Corp has an average volume of 271K.
15 different firms, including Barclays and Merrill Lynch, currently also have a Buy rating on the stock.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Bruker Corp. engages in the development, manufacture and distribution of scientific instruments, and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. It operates through the Bruker Scientific Instruments (BSI) and Bruker Energy and Supercon Technologies (BEST) segments.
